MDT vs PACB · P/E 21, rev $36.36B vs rev $76.2M
Medtronic PLC (MDT) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. PACB currently screens at market cap $387.1M.
Not investment advice. Open the MDT and PACB stock pages for the full models.
Not investment advice.